Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAL-PDT for Actinic Cheilitis
NCT03990636Phase 2Unknown
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Light/Condition-Responsive Prodrugs
01
Overview
A Phase 2 trial of methyl aminolevulinate in actinic cheilitis (AC), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Status: unknown.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic cheilitis (AC)
Beyond the preview
Go deeper on NCT03990636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03990636.